Burry vs Karp: One Year Later, Who Actually Won the Palantir Fight?

Palantir reported Q3 revenue of $2.313 billion versus $2.181 billion consensus and adjusted EPS of $0.44 versus $0.41; U.S. commercial revenue rose 148% to $984 million, and adjusted free cash flow guidance increased to $4.8 billion–$5.0 billion. The article says business results favor CEO Alex Karp, but shares fell in premarket trading and underperformed the S&P 500 over the year, while valuation remained stretched at 157 times earnings and 140 times free cash flow. Contract value growth was 6%, and stock-based compensation increased to $318.9 million from $172.3 million; the article presents Michael Burry’s valuation concerns as unresolved.

Analysis

The key tension is not whether Palantir can grow, but whether current growth is durable enough to support a valuation that leaves little room for execution slippage. The 6% TCV growth alongside strong reported results is a warning about forward conversion, not proof of a slowdown: verify deal duration, renewals, and backlog conversion before treating it as a trend. If bookings stay weak while revenue remains strong, the market may be extrapolating deployments faster than customers are committing.

Commercial momentum also changes the risk mix. It can broaden the growth engine beyond government procurement, but likely makes results more sensitive to enterprise budget cycles and competitive displacement. Rising stock-based compensation is a second-order concern: adjusted cash generation can look compelling while per-share value is diluted. Compare share-count growth and SBC as a share of revenue over several quarters, not just one quarter.

Karp won the operating debate; that does not settle the equity debate. Underperformance versus SPY is not evidence that a short has positive expected value: the sharp earnings repricing illustrates the asymmetric squeeze risk when expectations reset upward. Over the next 1–3 months, Q4 revenue delivery and TCV recovery are the catalysts. Over 6–18 months, the test is whether commercial growth converts into durable per-share cash flow. A sustained bookings slowdown, guidance cut, or continued dilution would strengthen the valuation bear case; accelerating TCV and stable share-count growth would weaken it.

Key Decisions for Investors

• Avoid an outright short at this stage: the valuation concern is real, but the upside gap risk around guidance and commercial demand is substantial. Reassess after Q4 results rather than extrapolating from the valuation multiple alone.
• For a bearish expression, consider a defined-risk PLTR put spread only after checking implied volatility and the cost of protection; avoid paying for event premium immediately before results. Thesis trigger: Q4 revenue misses the stated guide or subsequent TCV growth remains weak. Falsifier: bookings accelerate and guidance is raised again.
• Track TCV, revenue conversion, SBC, and diluted share count together. Treat strong revenue with persistently weak bookings or faster dilution as a quality-of-growth warning; do not infer a trend from a single quarter.
• Do not use SNOW as a mechanical short hedge: its reported operating profile and product-revenue metric are not directly comparable to PLTR's. Any relative-value position needs a separate valuation, growth, and estimate-revision review.